Summary Keywords ER/, GPER1/GPR30, 17-estradiol, bisphenol A, Alzheimers disease, Parkinsons disease, hormone replacement therapy, neural stem/progenitor cells Citation Bustamante-Barrientos FA, Mndez-Ruette M, Ortloff A, Luz-Crawford P, Rivera FJ, Figueroa CD, Molina L and Btiz LF (2021) The Impact of Estrogen and Estrogen-Like Molecules in Neurogenesis and Neurodegeneration: Beneficial or Harmful
The potential for altered food reward processing may benefit patients with binge eating patterns or food addiction-like behaviors, though GLP-1 medications lack specific FDA approval for eating disorders
For othersespecially those with higher demands, specific medications, metabolic issues, or aggressive weight-management planssupplementing into a higher, therapeutic range can make sense
Six trials were rated as low risk of bias
Increased immunolabeling for OS biomarkers has been observed in the retinal tissue of dogs with acute glaucoma [213], and lower antioxidant enzymes (GPX) have been related to an increased risk of inherited glaucoma in Euraiser dogs [212]
